SETDB1 and glioblastoma: Taken together, our study characterizes TRAF4 in glioblastoma and demonstrates that the E3 ubiquitin ligase TRAF4 can activate the AKT pathway by stabilizing the expression of SETDB1, ultimately promoting glioblastoma proliferation.